Positive data for Acesion’s atrial fibrillation candidates
The company intends to advance AF drugs that address current risk concerns with existing therapies
Read Moreby John Pinching | May 15, 2023 | News | 0
The company intends to advance AF drugs that address current risk concerns with existing therapies
Read Moreby Selina McKee | Feb 15, 2018 | News | 0
The NHS has launched a new device in England designed to accelerate the diagnosis of atrial fibrillation (AF), the most common arrhythmia and a contributing factor of up to one in five strokes in the UK.
Read Moreby Selina McKee | Oct 13, 2016 | News | 0
UK charity Arrhythmia Alliance is warning that hundreds of patients at high risk from suffering an atrial fibrillation (AF)-related stroke could be left without access to potentially life-saving, preventative treatment for months while a decision is made on its funding.
Read Moreby Selina McKee | Aug 2, 2016 | News | 0
The National Institute for Health and Care Excellence has published new indicators for healthcare professionals that could prevent thousands of people from having a stroke.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
